83 related articles for article (PubMed ID: 9247568)
1. Ras activation leads to cell proliferation or apoptotic cell death upon interleukin-2 stimulation or lymphokine deprivation, respectively.
Gómez J; Martínez C; Fernández B; García A; Rebollo A
Eur J Immunol; 1997 Jul; 27(7):1610-8. PubMed ID: 9247568
[TBL] [Abstract][Full Text] [Related]
2. Critical role of Ras in the proliferation and prevention of apoptosis mediated by IL-2.
Gómez J; Martínez-A C; Fernández B; García A; Rebollo A
J Immunol; 1996 Sep; 157(6):2272-81. PubMed ID: 8805624
[TBL] [Abstract][Full Text] [Related]
3. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
4. CD9-mediated costimulation of TCR-triggered naive T cells leads to activation followed by apoptosis.
Tai XG; Toyooka K; Yashiro Y; Abe R; Park CS; Hamaoka T; Kobayashi M; Neben S; Fujiwara H
J Immunol; 1997 Oct; 159(8):3799-807. PubMed ID: 9378967
[TBL] [Abstract][Full Text] [Related]
5. Distinct signals are required for proliferation and lymphokine gene expression in murine T cell clones.
Heckford SE; Gelmann EP; Agnor CL; Jacobson S; Zinn S; Matis LA
J Immunol; 1986 Dec; 137(11):3652-63. PubMed ID: 3097128
[TBL] [Abstract][Full Text] [Related]
6. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death.
Zheng L; Trageser CL; Willerford DM; Lenardo MJ
J Immunol; 1998 Jan; 160(2):763-9. PubMed ID: 9551911
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 differentially targets K-, N-, and H-Ras to mitochondria in IL-2 supplemented or deprived cells: implications in prevention of apoptosis.
Rebollo A; Pérez-Sala D; Martínez-A C
Oncogene; 1999 Sep; 18(35):4930-9. PubMed ID: 10490827
[TBL] [Abstract][Full Text] [Related]
8. CD 95-independent mechanisms of IL-2 deprivation-induced apoptosis in activated human lymphocytes.
Hieronymus T; Blank N; Gruenke M; Winkler S; Haas JP; Kalden JR; Lorenz HM
Cell Death Differ; 2000 Jun; 7(6):538-47. PubMed ID: 10822277
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression.
Akbar AN; Borthwick NJ; Wickremasinghe RG; Panayoitidis P; Pilling D; Bofill M; Krajewski S; Reed JC; Salmon M
Eur J Immunol; 1996 Feb; 26(2):294-9. PubMed ID: 8617294
[TBL] [Abstract][Full Text] [Related]
10. Lymphokine regulation of activation-induced apoptosis in T cells of IL-2 and IL-2R beta knockout mice.
Kung JT; Beller D; Ju ST
Cell Immunol; 1998 May; 185(2):158-63. PubMed ID: 9636694
[TBL] [Abstract][Full Text] [Related]
11. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.
Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG
J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma.
Memon SA; Moreno MB; Petrak D; Zacharchuk CM
J Immunol; 1995 Nov; 155(10):4644-52. PubMed ID: 7594463
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression.
Naora H; Gougeon ML
Cell Death Differ; 1999 Oct; 6(10):1002-11. PubMed ID: 10556978
[TBL] [Abstract][Full Text] [Related]
14. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.
Novelli F; Bernabei P; Ozmen L; Rigamonti L; Allione A; Pestka S; Garotta G; Forni G
J Immunol; 1996 Sep; 157(5):1935-43. PubMed ID: 8757312
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells.
Kinoshita T; Yokota T; Arai K; Miyajima A
Oncogene; 1995 Jun; 10(11):2207-12. PubMed ID: 7784065
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
Moreno MB; Memon SA; Zacharchuk CM
J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
[TBL] [Abstract][Full Text] [Related]
17. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal.
Broome HE; Dargan CM; Krajewski S; Reed JC
J Immunol; 1995 Sep; 155(5):2311-7. PubMed ID: 7650367
[TBL] [Abstract][Full Text] [Related]
18. Rho prevents apoptosis through Bcl-2 expression: implications for interleukin-2 receptor signal transduction.
Gómez J; Martínez C; Giry M; García A; Rebollo A
Eur J Immunol; 1997 Nov; 27(11):2793-9. PubMed ID: 9394801
[TBL] [Abstract][Full Text] [Related]
19. The role of caspase 3 and BclxL in the action of interleukin 7 (IL-7): a survival factor in activated human T cells.
Amos CL; Woetmann A; Nielsen M; Geisler C; Odum N; Brown BL; Dobson PR
Cytokine; 1998 Sep; 10(9):662-8. PubMed ID: 9770327
[TBL] [Abstract][Full Text] [Related]
20. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
